All Stories

  1. Can yoga have any effect on shoulder and arm pain and quality of life in patients with breast cancer? A randomized, controlled, single-blind trial

    Article • Complementary Therapies in Clinical Practice, April 2018, Elsevier

    Ruchan Uslu

  2. A national, multicenter, non-interventional, observational study on treatment patterns in patients with metastatic renal cell carcinoma in Turkey – NOTES study

    Article • OncoTargets and Therapy, March 2018, Dove Medical Press

    Ruchan Uslu

  3. The effect of chemotherapy on nutritional status and weakness in geriatric gastrointestinal system cancer patients

    Article • Nutrition, March 2018, Elsevier

    Ruchan Uslu

  4. Neuropathic pain is associated with sympathovagal activity in breast cancer

    Article • Neurological Research, February 2018, Taylor & Francis

    Ruchan Uslu, sibel eyigor

  5. Risk factors for poor mobilization in solid tumors: How effectively can we mobilize patients with solid tumors?

    Article • Transfusion and Apheresis Science, December 2017, Elsevier

    Ruchan Uslu

  6. Cytolytic tests with hyperimmune patient sera is a good prognostic tool in racotumomab immunotherapy in advanced non-small cell lung cancer

    Article • Advances in Modern Oncology Research, October 2017, PiscoMed Publishing Pte Ltd

    Ruchan Uslu

  7. Pazopanib: a novel treatment option for aggressive fibromatosis

    Article • Clinical Sarcoma Research, December 2016, Springer Science + Business Media

    Ruchan Uslu

  8. Reliability and validity of the Turkish version of the EORTC QLQ–C15–PAL for patients with advanced cancer

    Article • Palliative & Supportive Care, April 2016, Cambridge University Press

    Ruchan Uslu

  9. Comparative analysis of XTT assay and xCELLigence system by measuring cytotoxicity of resveratrol in human cancer cell lines

    Article • Turkish Journal of Biochemistry, January 2016, De Gruyter

    Ruchan Uslu

  10. Octreotide in combination with AT-101 induces cytotoxicity and apoptosis through up-regulation of somatostatin receptors 2 and 5 in DU-145 prostate cancer cells

    Article • Tumor Biology, November 2015, Springer Science + Business Media

    Ruchan Uslu

  11. Enhanced G2/M Arrest, Caspase Related Apoptosis and Reduced E-Cadherin Dependent Intercellular Adhesion by Trabectedin in Prostate Cancer Stem Cells

    Article • PLoS ONE, October 2015, PLOS

    Ruchan Uslu

  12. Combination of zoledronic acid and serine/threonine phosphatase inhibitors induces synergistic cytotoxicity and apoptosis in human breast cancer cells via inhibition of PI3K/Akt pathway

    Article • Tumor Biology, October 2015, Springer Science + Business Media

    Ruchan Uslu

  13. Capecitabine maintenance therapy following docetaxel/capecitabine combination treatment in patients with metastatic breast cancer

    Article • Oncology Letters, July 2015, Spandidos Publications

    Ruchan Uslu

  14. Importance of surveillance and risk factor evaluation in patients with multiple curable malignancies

    Article • European Journal of Cancer Prevention, July 2015, Wolters Kluwer Health

    Ruchan Uslu

  15. Reply To the Editor, Re: Bicakli et al. Adjuvant chemotherapy may contribute to an increased risk for metabolic syndrome in patients with breast cancer. J Oncol Pharm Pract, published online September 2014. DOI: 10.1177/1078155214551315

    Article • Journal of Oncology Pharmacy Practice, May 2015, SAGE Publications

    Ruchan Uslu

  16. Docetaxel in combination with octreotide shows synergistic apoptotic effect by increasing SSTR2 and SSTR5 expression levels in prostate and breast cancer cell lines

    Article • Cancer Chemotherapy and Pharmacology, April 2015, Springer Science + Business Media

    Ruchan Uslu

  17. The Role of Body Mass Index in Triple Negative Breast Cancer

    Article • Oncology Research and Treatment, January 2015, Karger Publishers

    Ruchan Uslu

  18. Zoledronic acid increases cytotoxicity by inducing apoptosis in hormone and docetaxel-resistant prostate cancer cell lines

    Article • Tumor Biology, October 2014, Springer Science + Business Media

    Ruchan Uslu

  19. Adjuvant chemotherapy may contribute to an increased risk for metabolic syndrome in patients with breast cancer

    Article • Journal of Oncology Pharmacy Practice, September 2014, SAGE Publications

    Ruchan Uslu

  20. Second-Line Capecitabine and Oxaliplatin Combination for Gemcitabine-Resistant Advanced Pancreatic Cancer

    Article • Asian Pacific Journal of Cancer Prevention, September 2014, Asian Pacific Organization for Cancer Prevention

    Ruchan Uslu

  21. Hypersensitivity to chemotherapeutics: a cross sectional study with 35 desensitisations

    Article • International Journal of Clinical Oncology, July 2014, Springer Science + Business Media

    Ruchan Uslu

  22. A Case of Listeria monocytogenes Bacteremia Treated with Levofloxacin

    Article • Mediterranean Journal of Infection Microbes and Antimicrobials, June 2014, Journal of Clinical Research of Pediatric Endocrinology

    Ruchan Uslu

  23. Determining the satisfaction levels of the family members of patients with advanced-stage cancer

    Article • Palliative & Supportive Care, June 2014, Cambridge University Press

    Ruchan Uslu

  24. First-Line Mono-Chemotherapy in Frail Elderly Patients with Metastatic Colorectal Cancer

    Article • Asian Pacific Journal of Cancer Prevention, April 2014, Asian Pacific Organization for Cancer Prevention

    Ruchan Uslu

  25. Expression profiling of stem cell signaling alters with spheroid formation in CD133high/CD44high prostate cancer stem cells

    Article • Oncology Letters, March 2014, Spandidos Publications

    Ruchan Uslu

  26. Each patients cancer is like fingerprint: where are we in molecular profiling in breast cancer diagnosis?

    Article • Medical Science and Discovery, March 2014, Medical Science and Discovery

    Ruchan Uslu

  27. Anticancer Therapy for Breast Cancer Patients with Skin Metastases Refractory to Conventional Treatments

    Article • Asian Pacific Journal of Cancer Prevention, February 2014, Asian Pacific Organization for Cancer Prevention

    Ruchan Uslu

  28. Survival Analysis of Triple Negative and Her2 Positive Breast Cancer Patients: Single Center Report

    Article • The Journal of Breast Health, January 2014, AVES Publishing Co.

    Ruchan Uslu

  29. Markers to Predict the Efficacy of Bevacizumab in the Treatment of Metastatic Colorectal Cancer

    Article • Tumori Journal, January 2014, SAGE Publications

    Ruchan Uslu

  30. Nine weeks versus 1 year adjuvant trastuzumab in patients with early breast cancer: an observational study by the Turkish Oncology Group (TOG)

    Article • Breast Cancer, December 2013, Springer Science + Business Media

    Ruchan Uslu

  31. Tumor characteristics and metastatic sites may predict bevacizumab efficacy in the first-line treatment of metastatic colorectal cancer

    Article • Molecular and Clinical Oncology, November 2013, Spandidos Publications

    Ruchan Uslu

  32. A diverse induction of apoptosis by trabectedin in MCF-7 (HER2−/ER+) and MDA-MB-453 (HER2+/ER−) breast cancer cells

    Article • Toxicology Letters, August 2013, Elsevier

    Ruchan Uslu

  33. Comparing Time to Disease Progression of Irinotecan and Oxaliplatin-based Chemotherapies in Colorectal Cancer Patients With Liver Only Metastasis

    Article • American Journal of Clinical Oncology, August 2013, Wolters Kluwer Health

    Ruchan Uslu

  34. Abstract 255: Expressionprofiling of stem cell signaling alters with spheroid formation in CD133high/CD44highprostate cancer stem cells.

    Article • Cancer Research, April 2013, American Association for Cancer Research (AACR)

    Ruchan Uslu

  35. Abstract 4072: Wnt1 gene expression alters heterogeneous population of prostate cancer cells; decreased expression pattern observed in CD133+/CD44+prostate cancer stem cells.

    Article • Cancer Research, April 2013, American Association for Cancer Research (AACR)

    Ruchan Uslu

  36. Predictive and prognostic values of Tau and BubR1 protein in prostate cancer and their relationship to the Gleason score

    Article • Cancer Immunology Immunotherapy, March 2013, Springer Science + Business Media

    Ruchan Uslu

  37. Secondary haematological malignancies in the BCIRG 001 study

    Article • The Lancet Oncology, March 2013, Elsevier

    Ruchan Uslu

  38. Examination of Pain Experiences of Cancer Patients in Western Turkey

    Article • Holistic Nursing Practice, January 2013, Wolters Kluwer Health

    Ruchan Uslu

  39. Bevacizumab + Capecitabine as Maintenance Therapy after Initial Bevacizumab + XELOX Treatment in Previously Untreated Patients with Metastatic Colorectal Cancer: Phase III ‘Stop and Go' Study Results - A Turkish Oncology Group Trial

    Article • Oncology, January 2013, Karger Publishers

    Ruchan Uslu

  40. Combination of AT-101/cisplatin overcomes chemoresistance by inducing apoptosis and modulating epigenetics in human ovarian cancer cells

    Article • Molecular Biology Reports, December 2012, Springer Science + Business Media

    Ruchan Uslu

  41. Effects ofThymus serpyllumExtract on Cell Proliferation, Apoptosis and Epigenetic Events in Human Breast Cancer Cells

    Article • Nutrition and Cancer, November 2012, Taylor & Francis

    Ruchan Uslu

  42. Zoledronic acid in combination with serine/threonine phosphatase inhibitors induces enhanced cytotoxicity and apoptosis in hormone-refractory prostate cancer cell lines by decreasing the activities of PP1 and PP2A

    Article • BJU International, August 2012, Wiley

    Ruchan Uslu

  43. Undifferentiated embryonal sarcoma of the liver in an adult patient: Case report

    Article • The Turkish Journal of Gastroenterology, June 2012, AVES Publishing Co.

    Ruchan Uslu

  44. Pretreatment with AT-101 enhances tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis of breast cancer cells by inducing death receptors 4 and 5 protein levels

    Article • Journal of Cancer Research and Clinical Oncology, March 2012, Springer Science + Business Media

    Ruchan Uslu

  45. The Frequency and Significance of Radiologically Detected Indeterminate Pulmonary Nodules in Patients with Colorectal Cancer

    Article • Medical Principles and Practice, January 2012, Karger Publishers

    Ruchan Uslu

  46. Cancer patients’ satisfaction with doctors and preferences about death in a university hospital in Turkey

    Article • Patient Education and Counseling, December 2011, Elsevier

    Ruchan Uslu

  47. Expression profiling of apoptotic proteins in human breast cancer cells treated with AT-101 by protein array technology

    Article • Current Opinion in Biotechnology, September 2011, Elsevier

    Ruchan Uslu

  48. Cytotoxic and Apoptotic Effect of Gossypol on Mouse Pituitary Corticotroph Tumor AtT20/D16v-F2 Cells: Could It Be a Novel Therapeutic Agent for Cushing Disease?

    Article • June 2011, Endocrine Society

    Ruchan Uslu

  49. p53 Protein Accumulation and Presence of Visceral Metastasis Are Independent Prognostic Factors for Survival in Patients with Metastatic Inflammatory Breast Carcinoma

    Article • Medical Principles and Practice, January 2011, Karger Publishers

    Ruchan Uslu

  50. Targeting Bcl-2 Protein to Enhance Chemosensitivity of Hormone Refractory Prostate Cancer Cell Line, DU-145 by a Synergistic Combination of Docetaxel and Gossypol

    Article • Turkiye Klinikleri Journal of Medical Sciences, January 2011, Ortadogu Reklam Tanitim Yayincilik Turizm Egitim Insaat Sanayi ve Ticaret A.S.

    Ruchan Uslu

  51. Assessment of pain, fatigue, sleep and quality of life (QoL) in elderly hospitalized cancer patients

    Article • Archives of Gerontology and Geriatrics, November 2010, Elsevier

    Ruchan Uslu

  52. Comparison of XTT and Alamar blue assays in the assessment of the viability of various human cancer cell lines by AT-101 (−/− gossypol)

    Article • Toxicology Mechanisms and Methods, September 2010, Taylor & Francis

    Ruchan Uslu

  53. Regulation of apoptosis-related molecules by synergistic combination of all-trans retinoic acid and zoledronic acid in hormone-refractory prostate cancer cell lines

    Article • Molecular Biology Reports, March 2010, Springer Science + Business Media

    Ruchan Uslu

  54. Enhancing cytotoxic and apoptotic effect in OVCAR-3 and MDAH-2774 cells with all-trans retinoic acid and zoledronic acid: a paradigm of synergistic molecular targeting treatment for ovarian cancer

    Article • Journal of Experimental & Clinical Cancer Research, January 2010, Springer Science + Business Media

    Ruchan Uslu

  55. Is it the time for metformin to take place in adjuvant treatment of Her-2 positive breast cancer? Teaching new tricks to old dogs

    Article • Medical Hypotheses, October 2009, Elsevier

    Ruchan Uslu

  56. Can gossypol be a hope for transsexual patients (male to female) before sex reassignment surgery? Just for adjusting the body to mind

    Article • Medical Hypotheses, October 2009, Elsevier

    Ruchan Uslu

  57. Evaluation of burnout syndrome in oncology employees

    Article • Cancer Immunology Immunotherapy, September 2009, Springer Science + Business Media

    Ruchan Uslu

  58. Regulation of growth factors in hormone- and drug-resistant prostate cancer cells by synergistic combination of docetaxel and octreotide

    Article • BJU International, July 2009, Wiley

    Ruchan Uslu

  59. Hopelessness in Turkish cancer inpatients: The relation of hopelessness with psychological and disease-related outcomes

    Article • European Journal of Oncology Nursing, April 2009, Elsevier

    Ruchan Uslu

  60. Overcoming drug resistance in hormone- and drug-refractory prostate cancer cell line, PC-3 by docetaxel and gossypol combination

    Article • Molecular Biology Reports, March 2009, Springer Science + Business Media

    Ruchan Uslu

  61. Prevalance And Management of Neuropathic Pain in Cancer Patients

    Article • The Anatolian Journal of General Medical Research, January 2009, Logos Medical Publication (Logos Yayincilik Tic. A.S.)

    Ruchan Uslu

  62. Comparison of Inflammatory Breast Cancer and Noninflammatory Breast Cancer in Western Turkey

    Article • Medical Principles and Practice, January 2008, Karger Publishers

    Ruchan Uslu

  63. Enhancement of docetaxel-induced cytotoxicity and apoptosis by all-trans retinoic acid (ATRA) through downregulation of survivin (BIRC5), MCL-1 and LTbeta-R in hormone- and drug resistant prostate cancer cell line, DU-145

    Article • Journal of Experimental & Clinical Cancer Research, January 2008, Springer Science + Business Media

    Ruchan Uslu

  64. Serum Her-2/neu and Survivin Levels and Their Relationship to Histological Parameters in Early-stage Breast Cancer

    Article • Journal of International Medical Research, March 2007, SAGE Publications

    Ruchan Uslu

  65. Quality of Life, Anxiety and Depression Status in Primary Caregivers of Hospitalized Cancer Patients

    Article • The Anatolian Journal of General Medical Research, January 2007, Logos Medical Publication (Logos Yayincilik Tic. A.S.)

    Ruchan Uslu

  66. Arsenic trioxide exposure to ovarian carcinoma cells leads to decreased level of topoisomerase II and cytotoxicity

    Article • International Journal of Gynecological Cancer, July 2006, Wolters Kluwer Health

    Ruchan Uslu

  67. Arsenic trioxide-loaded, microemulsion-enhanced cytotoxicity on MDAH 2774 ovarian carcinoma cell line

    Article • International Journal of Gynecological Cancer, March 2006, Wolters Kluwer Health

    Ruchan Uslu

  68. Single-Agent Irinotecan for Recurrent/Metastatic Colorectal Cancer: A Retrospective Analysis

    Article • Medical Principles and Practice, January 2006, Karger Publishers

    Ruchan Uslu

  69. Predictive value of serum interleukin-8 levels in ovarian cancer patients treated with paclitaxel-containing regimens

    Article • International Journal of Gynecological Cancer, March 2005, Wolters Kluwer Health

    Ruchan Uslu

  70. Potential Predictive Factors for Response to Weekly Paclitaxel Treatment in Patients with Metastatic Breast Cancer

    Article • Journal of Chemotherapy, February 2005, Taylor & Francis

    Ruchan Uslu

  71. Topotecan in Platinum-Resistant Epithelial Ovarian Cancer

    Article • Chemotherapy, January 2005, Karger Publishers

    Ruchan Uslu

  72. Gemcitabine treatment in patients with inoperable locally advanced/metastatic pancreatic cancer and prognostic factors

    Article • Scandinavian Journal of Gastroenterology, January 2005, Taylor & Francis

    Ruchan Uslu

  73. Differential Effects of Doxorubicin and Docetaxel on Nitric Oxide Production and Inducible Nitric Oxide Synthase Expression in MCF-7 Human Breast Cancer Cells

    Article • Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics, January 2004, Cognizant Communication Corporation

    Ruchan Uslu

  74. Alterations in the activity and expression of serine/threonine protein phosphatases during all trans retinoic acid-induced apoptosis in breast cancer cells

    Article • Oncology Reports, November 2003, Spandidos Publications

    Professor Hikmet Hakan Aydin, Ruchan Uslu

  75. Which dosing scheme is suitable for the taxanes? anin vitro model

    Article • Archives of Pharmacal Research, August 2002, Springer Science + Business Media

    Ruchan Uslu

  76. The Urinary Excretion of Glycosaminoglycans and Heparan Sulphate in Lupus Nephritis

    Article • Clinical Rheumatology, August 2002, Springer Science + Business Media

    Ruchan Uslu

  77. Arsenic trioxide and methylprednisolone use different signal transduction pathways in leukemic differentiation

    Article • Leukemia Research, April 2002, Elsevier

    Ruchan Uslu

  78. Doxazosin: a new cytotoxic agent for prostate cancer?

    Article • BJU International, December 2001, Wiley

    Ruchan Uslu

  79. Up-regulation of serine/threonine protein phosphatase type 2A regulatory subunits during methylprednisolone-induced differentiation of leukaemic HL-60 cells

    Article • International Journal of Laboratory Hematology, October 2000, Wiley

    Professor Hikmet Hakan Aydin, Ruchan Uslu

  80. Augmentation of methylprednisolone-induced differentiation of myeloid leukemia cells by serine/threonine protein phosphatase inhibitors

    Article • Leukemia Research, May 1999, Elsevier

    Ruchan Uslu

  81. Superior vena cava syndrome together with multiple venous thrombosis in Behçet's disease

    Article • Clinical Rheumatology, March 1998, Springer Science + Business Media

    Ruchan Uslu

  82. Sensitization of Human Ovarian Tumor Cells by Subtoxic CDDP to Anti-Fas Antibody-Mediated Cytotoxicity and Apoptosis

    Article • Gynecologic Oncology, August 1996, Elsevier

    Ruchan Uslu

  83. Involvement of the mitochondrion respiratory chain in the synergy achieved by treatment of human ovarian carcinoma cell lines with both tumor necrosis factor‐α and cis‐diamminedichloroplatinum

    Article • Cancer, February 1996, Wiley

    Ruchan Uslu

  84. Involvement of the mitochondrion respiratory chain in the synergy achieved by treatment of human ovarian carcinoma cell lines with both tumor necrosis factor-α and cis-diamminedichloroplatinum

    Article • Cancer, February 1996, Wiley

    Ruchan Uslu

  85. FREE-RADICALS DEPENDENT AND INDEPENDENT PATHWAYS OF CDDP-MEDIATED CYTOTOXICITY AND APOPTOSIS IN OVARIAN TUMOR-CELL LINES

    Article • International Journal of Oncology, May 1995, Spandidos Publications

    Ruchan Uslu